Tapering Effexor 37.5mg and Switching to Wellbutrin 150mg XR
Given that you're on the lowest dose of venlafaxine (37.5mg), taper it gradually over 1-2 weeks while simultaneously starting bupropion 150mg XR, then discontinue venlafaxine completely. This cross-taper approach minimizes withdrawal symptoms while establishing therapeutic levels of the new antidepressant.
Recommended Tapering Schedule
Week 1-2: Cross-Taper Phase
- Days 1-7: Continue Effexor 37.5mg daily + Start Wellbutrin XR 150mg in the morning
- Days 8-14: Reduce Effexor to 18.75mg daily (half tablet if scored, or every other day dosing) + Continue Wellbutrin XR 150mg
- Day 15 onward: Discontinue Effexor completely, continue Wellbutrin XR 150mg
Rationale for This Approach
Venlafaxine requires gradual tapering because withdrawal syndrome is well-documented 1, 2. The guidelines specifically note that "venlafaxine should be tapered when treatment is being discontinued because a withdrawal syndrome has been described" 2. At 37.5mg, you're already at the starting dose, which makes tapering more straightforward than higher doses.
Bupropion can be started at the target therapeutic dose of 150mg XR immediately 3. The FDA label for Wellbutrin XL states the recommended starting dose for MDD is 150mg once daily, which can be increased after 4 days if needed 3. However, since you're switching (not initiating treatment for the first time), maintaining 150mg is appropriate initially.
Key Clinical Considerations
Withdrawal Symptom Management
Venlafaxine has a short half-life and is associated with significant discontinuation symptoms 4, 5. Common withdrawal symptoms include:
- Dizziness and light-headedness
- Nausea and flu-like symptoms
- Sensory disturbances ("brain zaps")
- Anxiety and irritability
- Sleep disturbances
The cross-taper approach (overlapping medications) helps minimize these symptoms by maintaining some serotonergic activity while establishing noradrenergic/dopaminergic coverage with bupropion 5.
Why Not Taper More Slowly?
Research shows that tapering duration matters less than you might expect at low doses. A study comparing 3-day versus 14-day tapers found similar discontinuation syndrome rates (46% in both groups) 6. However, venlafaxine's short half-life makes it more problematic than other antidepressants 4, 5, so a 1-2 week taper from 37.5mg represents a reasonable middle ground.
Alternative: Fluoxetine Bridge (If Severe Withdrawal Occurs)
If you experience severe withdrawal symptoms during the taper, consider a fluoxetine bridge strategy: temporarily switch to fluoxetine 10-20mg for 1-2 weeks before discontinuing 7. Fluoxetine's long half-life (4-6 days) provides a "self-tapering" effect that can ease withdrawal. However, this adds complexity and is typically reserved for patients who fail standard tapering.
Monitoring and Safety
Watch For These Red Flags
- Worsening depression or suicidal ideation: Can emerge during antidepressant discontinuation 6. Four patients in one study developed emergent suicidal ideation when stopping paroxetine, highlighting this risk with SNRIs.
- Severe withdrawal symptoms: If symptoms are intolerable, resume the previous venlafaxine dose and taper more slowly (reduce by 25% every 2 weeks instead) 4
- Seizure risk: Bupropion lowers seizure threshold. Avoid if you have seizure history, brain metastases, or eating disorders 8
Drug Interaction Alert
Do not combine with MAOIs - allow 14 days between stopping an MAOI and starting bupropion, or vice versa 3. This includes linezolid and IV methylene blue.
Blood Pressure Monitoring
Venlafaxine can cause blood pressure increases 1, 2, so monitor BP during the taper, especially if you've been on it long-term. Bupropion can also affect BP but typically less so.
What to Expect
Most patients tolerate this switch well, but individual responses vary. The cross-taper provides continuous antidepressant coverage, reducing the risk of depressive relapse during the transition. Bupropion's activating properties may actually help counteract the fatigue and lethargy sometimes seen with venlafaxine withdrawal 9, 10.
If withdrawal symptoms persist beyond 2 weeks after complete venlafaxine discontinuation, they likely represent something other than withdrawal (e.g., inadequate treatment with bupropion, underlying anxiety) and warrant reassessment.